Clinical Trial: Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: A Phase I Study of Rindopepimut After Conventional Radiation in Children With Diffuse Intrinsic Pontine Gliomas
Brief Summary: This is a research study of patients with diffuse intrinsic pontine gliomas. We hope to learn about the safety and efficacy of treating pediatric diffuse intrinsic pontine glioma patients with the EGFRvIII peptide vaccine after conventional radiation.
Detailed Summary:
Sponsor: Paul Graham Fisher
Current Primary Outcome: Safety [ Time Frame: Monthly until death or until 5years ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Overall survival [ Time Frame: Monthly until death or until 5years ]
Original Secondary Outcome: Same as current
Information By: Stanford University
Dates:
Date Received: January 27, 2010
Date Started: June 2011
Date Completion:
Last Updated: October 22, 2013
Last Verified: October 2013